COMMUNIQUÉS West-GlobeNewswire

OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
02/12/2024
Continues IPOS Corporate Partnership as Emerald-Level Sponsor WARSAW, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on [...]
vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference
02/12/2024
HIGH POINT, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company with a portfolio of novel small molecules and a lead program in diabetes, today [...]
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
02/12/2024
FOSTER CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
02/12/2024
Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in [...]
Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
02/12/2024
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced completion of enrollment of the sentinel cohort of a Phase 2b clinical trial evaluating Vaxart’s oral pill COVID [...]
Cytokinetics to Participate in December Investor Conferences
02/12/2024
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in the following December investor conferences: 7 th [...]
M3 Group Joins MEDIROM Mother Labs’ Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation
02/12/2024
TOKYO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that M3, Inc. (TOKYO PRIME: 2413), or an affiliate within the M3 group, is participating in the Series A [...]
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
02/12/2024
YARDLEY, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its [...]
Foundation Fighting Blindness Partners with University of Colorado Anschutz Medical Campus and Other Leading Institutions to Secure Up to $46 Million to Fast Track Whole Eye Transplantation Program
02/12/2024
ARPA-H award establishes multi-disciplinary consortium of industry experts to address current limitations and advance innovative technologies for vision-restoring whole eye transplantation Goal to bring light to those [...]
OSE Immunotherapeutics Strengthens Leadership and Executive Committee
02/12/2024
OSE Immunotherapeutics Strengthens Leadership and Executive Committee NANTES, France, December 2, 2024 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , today announced that it has strengthened [...]
OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité Exécutif
02/12/2024
OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité Exécutif Nantes, France, le 2 décembre 2024, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , annonce aujourd’hui le [...]
HOOPP Board of Trustees appoints Annesley Wallace as new President & CEO
02/12/2024
HOOPP announces the appointment of Annesley Wallace as the new President & Chief Executive Officer (CEO), effective April 1, 2025 TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan ( [...]
Seegnal E-Health’s ‘Virtual Digital Pharmacist’ Approved for UK Government's G-Cloud 14 Framework
02/12/2024
TEL AVIV, Israel, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Seegnal eHealth Ltd. (“Seegnal” or the “Company”), an Israeli digital health provider, today announced that its UK distributor, Digitals UK, has secured a place for [...]
Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference
02/12/2024
DURHAM, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today [...]
Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024
02/12/2024
MIAMI, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
Health-ISAC Announces Board Members
02/12/2024
ORMOND BEACH, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center ( Health-ISAC ), the non-profit world-class, industry-led sharing organization that provides the global health sector [...]
Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
02/12/2024
Fast Track designation is designed to expedite clinical development and regulatory review timelines Enrolling patients in the GLEAM trial for SC291 in B-cell mediated autoimmune diseases, including systemic lupus [...]
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
02/12/2024
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’ latest GenesisX robotic system [...]
United Health Products Provides Update on Clinical Study Process
02/12/2024
MT. LAUREL, N.J., Dec. 02, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s planned clinical study. As previously disclosed, United Health Products is [...]

Pages